Bror Thomas Pollare

3i Plc operates as an private equity firm and provides investment advice. The company was founded on July 21, 1945 and is headquartered in London, the United Kingdom.

SSI Diagnostica A/S develops, produces, and sells in-vitro diagnostic products for clinical microbiology, veterinary diagnostics, food control, as well as environmental and hygiene control. The firm supplies a range of pneumococcal antigens and serotype specific capsular polysaccharides. The firm also markets antisera, bacterial strains, rapid tests, and animal blood products. The company was founded in 1998 and is headquartered in Hillerod, Denmark.

Psilox AB engages in the manufacture and application of bio ceramic materials. It offers calcium phosphate microspheres used in treatments in dentistry and medicine. The company was founded by Håkan Gunnar Engqvist and Wei Xia on May 29, 2013 and is headquartered in Uppsala, Sweden.

Carmel Pharma AB manufactures PhaSeal System, a clinically proven closed-system drug transfer device (CSTD) for the safe handling of hazardous drugs. The company expanded its safe handling initiatives to the U.S. market with the formation of Carmel Pharma, Inc., which operates a corporate office and distribution facility out of Columbus, OH. Carmel Pharma AB was founded in 1994 and is headquartered in Gothenburg, Sweden.

3i Nordic Plc (3i Nordic) is the Swedish venture capital subsidiary of 3i Group Plc (LSE: III) in Great Britain. Formerly known as Atle AB, founded in 1993, the firm was acquired by 3i in 2001 and renamed 3i Nordic. Located in Stockholm, 3i Nordic utilizes specialized 3i Group resources to provide financial experience, sector knowledge, company management practice and access to 3i's network of international contacts to investee companies. 3i Nordic is part of the 3i Nordic investment team which includes investment professionals from the Helsinki and Copenhagen offices.

Premacure AB owns shares and acquires securities, patents, rights and licenses from other businesses. It is also involved in biotechnology and medicine. The company is headquartered in Stockholm, Sweden.

Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark.

Gamma Knife Center Ecuador SA engages in the management of a healthcare institution. The firm specializes in the provision of stereotactic radiosurgery through a Gamma Knife unit to treat patients with tumors. The company was founded in 2009 and is headquartered in Guayaquil, Ecuador.

Sinfonia Biotherapeutics AB is a Swedish clinical stage company that develops biologics for neuropathic pain. The private company is based in Huddinge, Sweden.

Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ.

A3P Biomedical AB is a Swedish company that aims to improve the precision in prostate cancer diagnostics and treatment. A3P Biomedical is headquartered in Sweden and has subsidiaries in the country. The private company's lead product is Stockholm3, a blood test for early detection of aggressive prostate cancer. The test has been developed by scientists at Institutet and validated in clinical studies involving more than 80,000 men. A total of SEK 750 million has been invested in clinical research, product development, and market validation activities. The company sells Stockholm3 to healthcare providers through direct sales and distributors.